inhibering av influensavirus typ a ann arbor treaty h2n2 med antisensoligonukleotider

摘要

PCT No. PCT/US91/05742 Sec. 371 Date Sep. 22, 1992 Sec. 102(e) Date Sep. 22, 1992 PCT Filed Aug. 13, 1991 PCT Pub. No. WO92/03454 PCT Pub. Date Mar. 5, 1992Compositions and methods are provided for the treatment and diagnosis of influenza virus infections. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with viral RNAs. The oligonucleotide comprises nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a transcription initiation site, a translation initiation site, 5'-untranslated sequences, 3'-untranslated sequences, and intron/exon junction of influenza virus mRNAs. In additional preferred embodiments, the oligonucleotides are specifically hybridizable with RNA sequences involved in splicing of the viral RNA, or in viral packaging. Methods of treating animals suffering from influenza virus infection are disclosed.